- CGN Power reported revenue of 20 billion yuan for the first quarter of 2025.
- The company’s net income for the same period amounted to 3.03 billion yuan.
- Earnings per share (EPS) were recorded at 6.00 RMB cents.
- Analyst recommendations include 11 ‘buy’ ratings, indicating a majority of analysts view the stock positively.
- There are also 4 ‘hold’ ratings and 2 ‘sell’ ratings, showing investor sentiment is overall optimistic but mixed.
A look at CGN Power Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 5 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 4.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
CGN Power Co., Ltd., a company operating and managing nuclear power generating stations, is set for a positive long-term outlook based on the Smartkarma Smart Scores. With top scores in both Value and Dividend factors, CGN Power is positioned well in terms of its financial health and return potential for investors. Moreover, its strong Growth score reflects promising prospects for future expansion and development initiatives. While the company scores slightly lower in terms of Resilience and Momentum, overall, CGN Power demonstrates stability and a solid foundation for sustained growth in the long run.
CGN Power‘s strategic positioning as a key player in the nuclear power sector, with operational stations in Guangdong, Fujian, and Liaoning, coupled with its affiliation with China General Nuclear Power Corporation, further strengthens its position for continued success in the industry. Investors looking for a company with strong value, dividend payouts, growth potential, and a focus on nuclear power generation may find CGN Power a compelling choice for long-term investment.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
